229 related articles for article (PubMed ID: 21102413)
21. Pure (acute) erythroid leukemia: morphology, immunophenotype, cytogenetics, mutations, treatment details, and survival data among 41 Mayo Clinic cases.
Reichard KK; Tefferi A; Abdelmagid M; Orazi A; Alexandres C; Haack J; Greipp PT
Blood Cancer J; 2022 Nov; 12(11):147. PubMed ID: 36323674
[TBL] [Abstract][Full Text] [Related]
22. Re-evaluation of acute erythroid leukemia according to the 2016 WHO classification.
Chen Y; Pourabdollah M; Atenafu EG; Tierens A; Schimmer A; Chang H
Leuk Res; 2017 Oct; 61():39-43. PubMed ID: 28886412
[TBL] [Abstract][Full Text] [Related]
23. Shifting of erythroleukemia to myelodysplastic syndrome according to the revised WHO classification: Biologic and cytogenetic features of shifted erythroleukemia.
Ryu S; Park HS; Kim SM; Im K; Kim JA; Hwang SM; Yoon SS; Lee DS
Leuk Res; 2018 Jul; 70():13-19. PubMed ID: 29729583
[TBL] [Abstract][Full Text] [Related]
24. Immunophenotypical profiling of myeloid neoplasms with erythroid predominance using mass cytometry (CyTOF).
Maag AH; Swanton H; Kull M; Vegi NM; Feuring M
Cytometry A; 2023 Jul; 103(7):551-562. PubMed ID: 36647792
[TBL] [Abstract][Full Text] [Related]
25. Pure Erythroid Leukemia and Erythroblastic Sarcoma Evolving From Chronic Myeloid Neoplasms.
Li H; Hasserjian RP; Kroft SH; Harrington AM; Wheaton SE; Pildain A; Ewalt MD; Gratzinger D; Hosking P; Olteanu H
Am J Clin Pathol; 2016 Apr; 145(4):538-51. PubMed ID: 27124944
[TBL] [Abstract][Full Text] [Related]
26. Critical evaluation of the World Health Organization classification of myelodysplasia and acute myeloid leukemia.
Heaney ML; Golde DW;
Curr Oncol Rep; 2000 Mar; 2(2):140-3. PubMed ID: 11122835
[TBL] [Abstract][Full Text] [Related]
27. Relapse and cytogenetic evolution in myeloid neoplasms.
Ertz-Archambault N; Kelemen K
Panminerva Med; 2017 Dec; 59(4):308-319. PubMed ID: 29144072
[TBL] [Abstract][Full Text] [Related]
28. Erythroleukemia: a comparison between the previous FAB approach and the WHO classification.
Park S; Picard F; Azgui Z; Viguie F; Merlat A; Guesnu M; Leblond V; Dreyfus F
Leuk Res; 2002 May; 26(5):423-9. PubMed ID: 11916513
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemistry for p53 is a useful tool to identify cases of acute myeloid leukemia with myelodysplasia-related changes that are TP53 mutated, have complex karyotype, and have poor prognosis.
Fernandez-Pol S; Ma L; Ohgami RS; Arber DA
Mod Pathol; 2017 Mar; 30(3):382-392. PubMed ID: 27934876
[TBL] [Abstract][Full Text] [Related]
30. Clinical prognostic factors for survival and risk of progression to acute myeloid leukemia in patients with myelodysplastic syndromes with < 10% marrow blasts and non-unfavorable cytogenetic categories.
Falantes JF; Calderón C; Márquez Malaver FJ; Alonso D; Martín Noya A; Carrillo E; Martino ML; Montero I; González J; Parody R; Espigado I; Pérez-Simón JA
Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):144-52. PubMed ID: 23137720
[TBL] [Abstract][Full Text] [Related]
31. Acute leukemia with erythroid hyperplasia. Our experience on a series of cases with acute myeloid leukemia.
Selicean EC; Paţiu M; Cucuianu A; Dima D; Dobreanu M
Rom J Morphol Embryol; 2014; 55(1):23-7. PubMed ID: 24715161
[TBL] [Abstract][Full Text] [Related]
32. Double minute chromosomes in acute myeloid leukemia, myelodysplastic syndromes, and chronic myelomonocytic leukemia are associated with micronuclei, MYC or MLL amplification, and complex karyotype.
Huh YO; Tang G; Talwalkar SS; Khoury JD; Ohanian M; Bueso-Ramos CE; Abruzzo LV
Cancer Genet; 2016; 209(7-8):313-20. PubMed ID: 27318442
[TBL] [Abstract][Full Text] [Related]
33. Erythroleukemia: a need for a new definition.
Park S; Picard F; Dreyfus F
Leukemia; 2002 Aug; 16(8):1399-401. PubMed ID: 12145675
[TBL] [Abstract][Full Text] [Related]
34. Clinical characterization of acute myeloid leukemia with myelodysplasia-related changes as defined by the 2008 WHO classification system.
Weinberg OK; Seetharam M; Ren L; Seo K; Ma L; Merker JD; Gotlib J; Zehnder JL; Arber DA
Blood; 2009 Feb; 113(9):1906-8. PubMed ID: 19131546
[TBL] [Abstract][Full Text] [Related]
35. Acute Erythroleukemias, Acute Megakaryoblastic Leukemias, and Reactive Mimics: A Guide to a Number of Perplexing Entities.
Wang SA; Hasserjian RP
Am J Clin Pathol; 2015 Jul; 144(1):44-60. PubMed ID: 26071461
[TBL] [Abstract][Full Text] [Related]
36. Study of clinical, haematological and cytogenetic profile of patients with acute erythroid leukaemia.
Linu JA; Udupa MN; Madhumathi DS; Lakshmaiah KC; Babu KG; Lokanatha D; Babu MS; Lokesh KN; Rajeev LK; Rudresha AH
Ecancermedicalscience; 2017; 11():712. PubMed ID: 28144286
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic criteria for hypocellular acute leukemia: a clinical entity distinct from overt acute leukemia and myelodysplastic syndrome.
Nagai K; Kohno T; Chen YX; Tsushima H; Mori H; Nakamura H; Jinnai I; Matsuo T; Kuriyama K; Tomonaga M; Bennett JM
Leuk Res; 1996 Jul; 20(7):563-74. PubMed ID: 8795690
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathologic features and outcome of acute erythroid leukemia based on 2008 revised World Health Organization classification.
Liu CJ; Hong YC; Yang CF; Liu SH; Gau JP; Liu JH; Hsiao LT; Liu CY; Yu YB; Tzeng CH
Leuk Lymphoma; 2012 Feb; 53(2):289-94. PubMed ID: 21780998
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathologic analysis of acute myeloid leukemia arising from chronic myelomonocytic leukemia.
Courville EL; Wu Y; Kourda J; Roth CG; Brockmann J; Muzikansky A; Fathi AT; de Leval L; Orazi A; Hasserjian RP
Mod Pathol; 2013 Jun; 26(6):751-61. PubMed ID: 23307061
[TBL] [Abstract][Full Text] [Related]
40. Philadelphia chromosome-negative acute leukemia in patients with chronic myeloid leukemia.
Gong Z; Xu ML; Chen M; Cui W; Kantarjian HM; Cortes JE; Zhou T; Tang G; Wang W; Medeiros LJ; Hu S
Am J Hematol; 2019 Oct; 94(10):E256-E259. PubMed ID: 31273842
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
